Retinopathy of prematurity (ROP) is a retinal disease that affects 20-70% of premature infants. If left untreated, it can cause visual impairment and blindness. Today, ROP accounts for up to 60% of childhood blindness; it is the leading cause of childhood blindness worldwide. Currently, less than 30% of neonatal intensive care units (NICUs) have the ability to perform the recommended screening for ROP due to the scarcity of pediatric ophthalmologists. At Kaleyedos, we aim to reduce the global incidence of ROP-induced visual impairment by providing a telemedicine solution to ROP screening: the Kaleyedos Imaging Device (KID).